Search

Search Constraints

You searched for: Author/Creator Meng, R.

Search Results

2. A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer. (February 2019)